<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/250105-an-industrial-scale-method-of-obtaining-an-enantiomer-of-modafinil by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 14:37:17 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 250105:AN INDUSTRIAL SCALE METHOD OF OBTAINING AN ENANTIOMER OF MODAFINIL</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">AN INDUSTRIAL SCALE METHOD OF OBTAINING AN ENANTIOMER OF MODAFINIL</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The invention relates to an industrial scale method of obtaining an enantiomer of modafinil comprising the steps of forming a solution of racemic modafinil; and subjecting the racemic modafinil solution to continuous chromatography to separate the enantiomers of modafinil and obtain at least one of the enantiomers in an industrial scale quantity; wherein the continuous chromatography is performed with: an organic solvent mobile phase chosen from C1-C10 alkanes, C1- C6 alcohols, acetates and propionates of C1-C6 alcohols, C1-C10 ketones, C1-C10 ethers, halogenated C1-C10 hydrocarbons, trifluoroacetic acid, dimethylformamide, dimethylacetamide, acetonitrile and combinations thereof; and a derivatized polysaccharide chiral stationary phase chosen from the amylosic, cellusosic, chitosan, xylan, curdlan, dextran, and inulan class of polysaccharides, and combinations thereof.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>METHODS FOR THE SEPARATION OF MODAFINIL<br>
BACKGROUND OF THE INVENTION<br>
This invention relates to chromatographic processes for obtaining<br>
optically active modafinil compounds, including the levorotatory enantiomer,<br>
(-)-benzhydrilsulfinylacetamide ("armodafinil"), and the dextrorotatory<br>
enantiomer, (+)-benzhydrilsulfinylacetamide. Such processes include<br>
commercially viable methods for producing armodafinil on an industrial scale<br>
suitable for pharmaceutical use. Racemic modafinil is the active agent in the<br>
pharmaceutical product Provigil®, which has been approved by the United<br>
States Food and Drug Administration for use in the treatment of excessive<br>
daytime sleepiness associated with narcolepsy, and to improve wakefulness<br>
in patients with excessive sleepiness associated with obstructive sleep<br>
apnea/hypopnea syndrome and shift work sleep disorder.<br>
The levorotatory isomer of modafinil and processes for its preparation<br>
have been described in U.S. Pat. No. 4,927,855 ("the '855 patent"), which is<br>
incorporated herein in its entirety. The '855 patent details the preparation of<br>
the levorotatory isomer by achiral synthesis. This process is not sufficiently<br>
robust to produce armodafinil on an industrial scale in pharmaceutically<br>
acceptable purities. It would be of significant advantage to obtain armodafinil<br>
in large quantities that meet acceptable pharmaceutical standards.<br>
A variety of methods have been utilized to obtain compounds in<br>
stereochemically pure form. Stereoisomers can be synthesized using<br>
asymmetric synthetic techniques, however such syntheses often require<br>
expensive reagents. Alternatively, stereoisomers can be obtained by<br>
selective recrystallization of one stereoisomer, however such a process<br>
cannot be used for all compounds, and may not be useful for enantiomeric<br>
separations. In addition, the process is considered inefficient, in that product<br>
recovery is often low and purity uncertain. Stereoisomers can also be<br>
resolved chromatographically, although the large amount of solvent required<br>
for conventional batch chromatography is cost prohibitive and results in the<br><br>
preparation of relatively dilute products. Limited throughput volumes also<br>
often make batch chromatography impractical for large-scale production.<br>
Moreover, the number of technical parameters required for its applicability on<br>
an industrial scale makes it difficult to select appropriate conditions for the<br>
mass production of pharmaceutically viable amounts of an enantiomeric<br>
compound. Determination of the conditions necessary for productive<br>
separation of enantiomers has been found by those of ordinary skill in the art<br>
to be a matter of trial and error. Even so, it is a common for those skilled in<br>
the art to find chiral separation of certain chiral mixtures to be inefficient or<br>
ineffective. In the instant case, these problems are heightened by the relative<br>
difficulty in solubilizing modafinil in many common solvents. The object of the<br>
present invention is to provide an efficient process for the separation of the<br>
modafinil enantiomers from racemic modafinil that provides a viable<br>
combination of selectivity and resolution at high throughput volumes or in<br>
bulk amounts.<br>
Hence, the present invention is directed to producing optically pure<br>
armodafinil at relatively low cost and with optimized productivity on a<br>
commercially viable scale. It has been found that multi-column continuous<br>
chromatography processes are capable of providing large scale, industrial<br>
enantiomeric separation of racemic modafinil, and in particular for the<br>
preparation of armodafinil. In particular, the necessary operational<br>
parameters have been found to yield an excellent degree of separation of the<br>
stereoisomers of modafinil with sufficiently robust productivity on a large<br>
scale. These multicolumn continuous chromatographic processes overcome<br>
certain limitations in classical batch chromatography, such as having<br>
increased productivity, lower eluent composition and higher robustness,<br>
resulting in lower final purification costs.<br>
SUMMARY OF THE INVENTION<br>
The present invention provides an improved process for the isolation<br>
of the enantiomeric forms of modafinil with high enantiomeric purity and high<br>
overall yields. Thus the present invention provides processes for obtaining an<br><br>
enantiomer of modafinil, and in particular, the levorotatory isomer of<br>
modafinil, by forming a solution of racemic modafinil and separating the<br>
enantiomers of modafinil by means of a continuous chromatographic<br>
process. The continuous chromatographic process includes, but is not limited<br>
to a countercurrent chromatographic process, such as a simulated moving<br>
bed ("SMB") process, or a non-steady state system, such as the Varied™<br>
process, which uses at least two columns packed with an optical resolution<br>
packing material from the amylosic or cellulosic class of polysaccharides or<br>
chemically modified forms thereof.<br>
In an additional embodiment of the present invention, there is provided<br>
a method for chromatographically resolving at least one enantiomer<br>
(preferably armodafinil) from a racemic mixture of modafinil using<br>
multicolumn continuous chromatography, wherein the continuous<br>
chromatographic method comprises a liquid mobile phase comprising a least<br>
one solvent and a solid chiral stationary phase comprising a derivatized<br>
polysaccharide that is selected from the amylosic, cellulosic, chitosan, xylan,<br>
curdlan, dextran, and inulan class of polysaccharides.<br>
DETAILED DESCRIPTION<br>
The processes of the present invention can utilize any<br>
chromatographic method for separating racemic modafinil to produce<br>
optically pure armodafinil. Such methods include, but are not limited to,<br>
traditional single column batch chromatography, continuous chromatography,<br>
or a steady state, sequential injection process (as described in, for example,<br>
U.S. Pat. No. 5,630,943 and PCT Publ. No. WO 98/51391). Continuous<br>
chromatographic methods include, but are not limited to multicolumn<br>
continuous chromatographic processes, including such countercurrent<br>
chromatographic processes as SMB, or a non-steady state continuous<br>
chromatographic method known as the "Varicol™" process.<br>
The SMB process is a continuous system that simulates counter-<br>
current flows to perform the chromatographic separation. The separation is<br>
achieved using a set of fixed-bed columns packed with a solid stationary<br><br>
phase; ports for the continuous introduction of solvent desorbent (mobile<br>
phase) and feed; ports for the continuous removal of raffinate (solution<br>
containing the less strongly retained enantiomer) and extract (solution<br>
containing the more strongly retained enantiomer); and a means of recycling<br>
fluid through the system, if necessary. In a closed loop system, the columns<br>
are connected such that the outlet of each column is connected to the inlet of<br>
the next column also with the outlet of the last column being connected to the<br>
inlet of the first column. Other implementations of the SMB process include<br>
an open loop system which can include 4-zone systems with external<br>
recycling or other 3-zone systems. All the inlet and outlet ports are shifted<br>
substantially simultaneously at substantially fixed time intervals in the fluid<br>
flow direction to simulate counter-current flow between the liquid phase and<br>
the solid phase. For the separation of stereoisomers, a chiral stationary<br>
phase ("CSP") capable of chiral recognition is often employed.<br>
The Varicol™ process is a non-steady state continuous separation<br>
process and is more fully described in U.S. Pat. No. 6,136,198, as well as in<br>
U.S. Pat. Nos. 6,375,839; 6,413,419; and 6,712,973 (all incorporated herein<br>
by reference in their entireties). This non-steady state process differs from<br>
the SMB process in that the inlet and outlet ports are not all shifted at the<br>
same time. The column distribution between zones does not stay the same<br>
during the period because the lines are shifted at different times, so the<br>
column allocation differs accordingly. In this process, there is no limitation on<br>
the number of configurations for a given number of columns, thereby giving<br>
the non-steady state process a greater degree of flexibility as compared to<br>
the SMB process. The potential for variation of the average length of given<br>
zones represented by column sections during the chromatographic<br>
separation can lead to an increase efficiency by using less columns, reducing<br>
the amount of the solid phase and solvent(s), and increasing higher purity<br>
yields.<br>
In one aspect of the present invention, a five to six column-four<br>
variable zone Varicol™ system may be used. The zones vary in length during<br>
operation, and have an average rather than fixed length in a given operation<br><br>
cycle. In another aspect, a three column-four variable zone Varicol™ system<br>
is used, a system which cannot be utilized in a SMB process, as at least four<br>
columns with four zones are necessary to simulate the true moving bed<br>
system. For the SMB process, the minimal number of columns required for<br>
the separation is equal to the number of zones of the system, whereas the<br>
number of columns can be smaller than the number of zones in the Varicol™<br>
system<br>
In another aspect of the present invention the chiral stationary phase<br>
is derivatized with at least one sugar derivative, and in particular is a<br>
derivatized polysaccharide that is selected from the amylosic, cellulosic,<br>
chitosan, xylan, curdlan, dextran, and inulan class of polysaccharides. In<br>
certain embodiments, the chiral stationary phase is a member of the amylosic<br>
or cellulosic class of polysaccharides. Esters and carbamates of these<br>
materials in particular are suitable. In additional embodiments, the chiral<br>
stationary phase is selected from cellulose phenyl carbamate derivatives,<br>
such as cellulose tris (3,5-dimethylphenyl) carbamate (available from Daicel<br>
Chemical Industries, Ltd. as "Chiralcel OD"); cellulose tribenzoate<br>
derivatives, such as cellulose tris 4-methylbenzoate (available from Daicel<br>
Chemical Industries, Ltd. as "Chiralcel OJ"); cellulose tricinnamate (available<br>
from Daicel Chemical Industries, Ltd. as "Chiralcel OK"); amylose phenyl and<br>
benzyl carbamate derivatives, such as amylose tris [(S)-α-methyl<br>
benzylcarbamate] (available from Daicel Chemical Industries, Ltd. as<br>
"Chiralpak AS"), amylose tris (3,5-dimethylphenyl) carbamate (available from<br>
Daicel Chemical Industries, Ltd. as "Chiralpak AD", or as "Chiralpak IA",<br>
wherein the carbamate derivative is bonded to the amylosic backbone),<br>
amylose 3,4-substituted phenyl carbamate, and amylose 4-substituted<br>
phenyl-carbamate; and amylose tricinnamate.<br>
Typically, the polysaccharide derivative is bonded or coated on silica<br>
gel, zirconium, alumina, ceramics and other silicas, and preferably on silica<br>
gel. Although the average particle diameter of the packing material varies<br>
depending on the volume flow rate of the solvent flowing in the<br>
chromatographic system, it is usually 1 to 300 µm, preferably 2 to 100 µm,<br><br>
more preferably 5 to 75 µm and most preferably 10 to 30 µm. As is known in<br>
the art, the selection of the average particle diameter of the packing material<br>
will help to adjust the pressure drop in the continuous chromatographic<br>
process and the efficiency of the packing material.<br>
In a further aspect of the present invention, the mobile phase an<br>
organic solvent selected from the group consisting of C1-C10 alkanes,<br>
including hexane and heptane; alcohols (C1-C6) such as methanol, ethanol,<br>
propanol, isopropanol, butanol; acetates and propionates of these alcohols;<br>
ketones (C1-C10) such as acetone, butanone, isopropyl-methylketone; ethers<br>
(C1-C10) such as diethyl ether, diisopropyl ether, tertbutylmethyl ether,<br>
tetrahydrofuran, dioxane; halogenated hydrocarbons (C1-C10) such as<br>
methylene chloride, chloroform, chlorobenzene, fluorinated alkanes;<br>
trifluoroacetic acid; dimethylformamide; dimethylacetamide; and acetonitrile,<br>
and combinations therein. In certain aspects, the mobile phase is a polar<br>
solvent, preferably a C1-C6 alcohol, and more preferably is methanol.<br>
In other aspects, any of the solvents listed above can be combined to<br>
produce the desired chromatographic separations. In particular, the primary<br>
solvent can be a C1-C6 alcohol, and more preferably is methanol. The<br>
secondary solvent can be a C1-C6 alcohol, and in particular, can be ethanol<br>
or isopropanol. Thus, certain eluent mixtures can include methanol/<br>
isopropanol wherein the eluent preferably contains at least 50% by volume of<br>
methanol. Alternatively the eluent may contain at least 60%, 70%, 80%, or<br>
90% by volume of methanol.<br>
A feature of the present invention is the adjustment of the<br>
chromatographic conditions to obtain the desired enantiomer of modafinil<br>
(preferably armodafinil) in at least 95% enantiomeric excess. Alternatively,<br>
the desired enantiomer of modafinil (preferably armodafinil) is recovered in at<br>
least 96%, 97%, 98%, 99% enantiomeric excess, and preferably in greater<br>
than 98 or 99% enantiomeric excess.<br>
Another feature of the present invention provides for adjusting or<br>
modifying the chromatographic conditions to obtain the desired enantiomer<br>
(preferably armodafinil) in at least 90% yield. Alternatively, the desired<br><br>
enantiomer of modafinil (preferably armodafinil) is recovered in at least a<br>
91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% yield, and preferably<br>
greater than a 90 or 95% yield.<br>
Examples<br>
The following examples show representative parameters for the<br>
isolation of the levorotatory enantiomer of modafinil. Other column<br>
configurations can be utilized for the chiral separations described herein,<br>
including but not limited to 1.3 / 2.3 /1.6 / 0.8; or 1 / 2.45 /1.85 / 0.7.<br><br><br><br><br><br>
While preferred embodiments of the present invention have been<br>
shown and described, it will be understood by those skilled in the art that<br>
various changes or modifications can be made without varying from the<br>
scope of the invention.<br><br>
We Claim:<br>
1. An industrial scale method of obtaining an enantiomer of modafinil<br>
comprising the steps of:<br>
a)	forming a solution of racemic modafinil; and<br>
b)	subjecting the racemic modafinil solution to continuous chromatography<br>
to separate the enantiomers of modafinil and obtain at least one of the<br>
enantiomers in an industrial scale quantity;<br>
wherein the continuous chromatography is performed with:<br>
(i) an organic solvent mobile phase chosen from C1-C10 alkanes, C1-C6<br>
alcohols, acetates and propionates of C1-C6 alcohols, C1-C10 ketones,<br>
C1-C10 ethers, halogenated C1-C10 hydrocarbons, trifluoroacetic acid,<br>
dimethylformamide, dimethylacetamide, acetonitrile and combinations<br>
thereof; and<br>
(ii) a derivatized polysaccharide chiral stationary phase chosen from the<br>
amylosic, cellusosic, chitosan, xylan, curdlan, dextran, and inulan class<br>
of polysaccharides, and combinations thereof.<br><br>
2.	The method as claimed in claim 1 wherein the levorotatory isomer of<br>
modafinil is obtained.<br>
3.	The method as claimed in claim 1 wherein the chromatographic method is<br>
multicolumn non-steady state continuous chromatography.<br>
4.	The method as claimed in claims 1 or 3, wherein the chiral stationary<br>
phase is chosen from cellulose tris 4-methylbenzoate; celluslose<br>
tricinnamate; amylose tris [(S)-α-methyl benzylcarbamate]; and amylose<br>
tris (3,5-dimethylphenyl) carbamate.<br>
5.	The method as claimed in claim 4, wherein the chiral stationary phase is<br>
amylose tris (3,5-dimethylphenyl) carbamate.<br>
6.	The method as claimed in claim 1, wherein the solvent is selected from<br>
hexane, heptane, methanol, ethanol, propanol, isopropanol, butanol,<br>
methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl<br>
acetate, methyl propionate, ethyl propionate, propyl propionate, isopropyl<br>
propionate, acetone, butanone, isopropyl methylketone, diethyl ether,<br><br>
diisopropyl ether, tertbutylmethyl ether, tetrahydrofuran, dioxane, methylene<br>
chloride, chloroform, chlorobenzene, trifluoroacetic acid, dimethylformamide,<br>
dimethylacetamide, acetonitrile and combinations thereof.<br>
7.	The method as claimed in claim 6, wherein the solvent is methanol.<br>
8.	The method as claimed in claim 6, wherein the solvent is a mixture of<br>
methanol and isopropanol.<br>
9.	The method as claimed in claim 2, wherein the solvent is methanol,<br>
isopropanol, or a mixture thereof, and the chiral stationary phase is<br>
chosen from cellulose tris 4-methylbenzoate; cellulose tricinnamate;<br>
amylose tris [(S)- )-α-methyl benzylcarbamate]; and amylose tris (3,5-<br>
dimethylphenyl) carbamate.<br>
10.The method as claimed in claim 9, wherein the chiral stationary phase is<br>
amylose tris (3,5-dimethylphenyl) carbamate.<br><br>
11.The method as claimed in claims 2 or 10, wherein the levorotatory<br>
enantiomer of modafinil is recovered in at least 95% enantiomeric excess.<br>
12.The method as claimed in claim 11, wherein the levorotatory enantiomer<br>
of modafinil is recovered in at least 98% enantiomeric excess.<br>
13.The method as claimed in claim 12, wherein the levorotatory enantiomer<br>
of modafinil is recovered in at least 99% enantiomeric excess.<br>
14.The method as claimed in claims 2 or 10, wherein the levorotatory<br>
enantiomer of modafinil is recovered in at least a 90% yield.<br>
15.The method as claimed in claim 14, wherein the levorotatory enantiomer<br>
of modafinil is recovered in at least a 93% yield.<br>
16. An industrial scale method for chromatographically resolving at least one<br>
enantiomer from a racemic mixture of modafinil using multicolumn<br>
continuous chromatography, the continuous chromatography comprising:<br>
a) at least one organic solvent mobile phase; and<br><br><br>
b) a derivatized polysaccharide chiral stationary phase that is selected<br>
from the amylosic, cellulosic, chitosan, xylan, curdlan, dextran, and<br>
inulan class of polysaccharides;<br>
wherein the method is performed at an industrial scale.<br>
17.The method as claimed in claim 16, wherein the resolved enantiomer is<br>
the levorotatory isomer of modafinil.<br>
18.The method as claimed in claim 16, wherein the continuous<br>
chromatographic method is multicolumn non-steady state continuous<br>
chromatography.<br>
19.The method as claimed in claim 16, wherein the solvent is selected from<br>
methanol or isopropanol, or a mixture thereof, and wherein the chiral<br>
stationary phase is selected from cellulose tris 4-methylbenzoate; cellulose<br>
tricinnamate; amylose tris [(S)-α-methyl benzylcarbamate]; and amylose<br>
tris (3,5-dimethylphenyl) carbamate.<br>
20.The method as claimed in claim 19, wherein the chiral stationary phase is<br>
amylose tris (3,5-dimethylphenyl)carbamate.<br><br>
21.The method as claimed in claims 16 or 20, wherein the levorotatory<br>
enantiomer of modafinil is recovered in at least 95% enantiomeric excess.<br>
22.The method as claimed in claim 21, wherein the levorotatory enantiomer<br>
of modafinil is recovered in at least 98% enantiomeric excess.<br>
23.The method as claimed in claim 22, wherein the levorotatory enantiomer<br>
of modafinil is recovered in at least 99% enantiomeric excess.<br>
24.The method as claimed in claims 16 or 20, wherein the levorotatory<br>
enantiomer of modafinil is recovered in at least a 90% yield.<br>
25.The method as claimed in claim 24, wherein the levorotatory enantiomer<br>
of modafinil is recovered in at least a 93% yield.<br><br><br>
The invention relates to an industrial scale method of obtaining an enantiomer of<br>
modafinil comprising the steps of forming a solution of racemic modafinil; and<br>
subjecting the racemic modafinil solution to continuous chromatography to<br>
separate the enantiomers of modafinil and obtain at least one of the enantiomers<br>
in an industrial scale quantity; wherein the continuous chromatography is<br>
performed with: an organic solvent mobile phase chosen from C1-C10 alkanes, C1-<br>
C6 alcohols, acetates and propionates of C1-C6 alcohols, C1-C10 ketones, C1-C10<br>
ethers, halogenated C1-C10 hydrocarbons, trifluoroacetic acid,<br>
dimethylformamide, dimethylacetamide, acetonitrile and combinations thereof;<br>
and a derivatized polysaccharide chiral stationary phase chosen from the<br>
amylosic, cellusosic, chitosan, xylan, curdlan, dextran, and inulan class of<br>
polysaccharides, and combinations thereof.<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0NjUta29sbnAtMjAwNyBjb3Jlc3Nwb25kZW5jZS0xLjMucGRm" target="_blank" style="word-wrap:break-word;">00465-kolnp-2007 coresspondence-1.3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0NjUta29sbnAtMjAwNyBjb3JyZXNwb25kZW5jZS0xLjIucGRm" target="_blank" style="word-wrap:break-word;">00465-kolnp-2007 correspondence-1.2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0NjUta29sbnAtMjAwNyBvdGhlcnMgZG9jdW1lbnQucGRm" target="_blank" style="word-wrap:break-word;">00465-kolnp-2007 others document.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0NjUta29sbnAtMjAwNyBwLmEucGRm" target="_blank" style="word-wrap:break-word;">00465-kolnp-2007 p.a.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0NjUta29sbnAtMjAwNy1hc3NpZ25tZW50LnBkZg==" target="_blank" style="word-wrap:break-word;">00465-kolnp-2007-assignment.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0NjUta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZS0xLjEucGRm" target="_blank" style="word-wrap:break-word;">00465-kolnp-2007-correspondence-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGNvcnJlc3BvbmRlbmNlIG90aGVycy5wZGY=" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 correspondence others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGRlc2NyaXB0aW9uKGNvbXBsZXRlKS5wZGY=" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 description(complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGZvcm0tMS5wZGY=" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 form-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGZvcm0tMi5wZGY=" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 form-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGZvcm0tMy5wZGY=" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 form-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGZvcm0tNS5wZGY=" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 form-5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGludGVybmF0aW9uYWwgcHVibGljYXRpb24ucGRm" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 international publication.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IGludGVybmF0aW9uYWwgc2VhcmNoIGF1dGhvcml0eSByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 international search authority report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IHBjdCBmb3JtLnBkZg==" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 pct form.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NS1rb2xucC0yMDA3IHByaW9yaXR5IGRvY3VtZW50LnBkZg==" target="_blank" style="word-wrap:break-word;">0465-kolnp-2007 priority document.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctKDI4LTEwLTIwMTEpLVBFVElUSU9OIFVOREVSIFJVTEUgMTM3LnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-(28-10-2011)-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctMDctMDktMjAxMi1GT1JNLTI3LnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-07-09-2012-FORM-27.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctQUJTVFJBQ1QucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctQU1BTkRFRCBDTEFJTVMucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-AMANDED CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctQVNTSUdOTUVOVC5wZGY=" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-ASSIGNMENT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctQ09SUkVTUE9OREVOQ0UucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctREVTQ1JJUFRJT04gKENPTVBMRVRFKS5wZGY=" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRVhBTUlOQVRJT04gUkVQT1JUIFJFUExZIFJFQ0lFVkVELnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-EXAMINATION REPORT REPLY RECIEVED.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRVhBTUlOQVRJT04gUkVQT1JULnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRk9STSAxLnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-FORM 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LWtvbG5wLTIwMDctZm9ybSAxOC5wZGY=" target="_blank" style="word-wrap:break-word;">465-kolnp-2007-form 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRk9STSAyLnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-FORM 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRk9STSAyNi5wZGY=" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-FORM 26.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRk9STSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRk9STSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-FORM 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRk9STS0yNy0xLjEucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-FORM-27-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctRk9STS0yNy5wZGY=" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-FORM-27.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctR1JBTlRFRC1BQlNUUkFDVC5wZGY=" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-GRANTED-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctR1JBTlRFRC1DTEFJTVMucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-GRANTED-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctR1JBTlRFRC1ERVNDUklQVElPTiAoQ09NUExFVEUpLnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-GRANTED-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctR1JBTlRFRC1GT1JNIDEucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-GRANTED-FORM 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctR1JBTlRFRC1GT1JNIDIucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-GRANTED-FORM 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctR1JBTlRFRC1TUEVDSUZJQ0FUSU9OLnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-GRANTED-SPECIFICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctT1RIRVJTLnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctT1RIRVJTMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-OTHERS1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctUEEucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-PA.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctUENUIFNFQVJDSCBSRVBPUlQucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-PCT SEARCH REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctUEVUSVRJT04gVU5ERVIgUlVMUiAxMzcucGRm" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-PETITION UNDER RULR 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1LUtPTE5QLTIwMDctUkVQTFkgVE8gRVhBTUlOQVRJT04gUkVQT1JULnBkZg==" target="_blank" style="word-wrap:break-word;">465-KOLNP-2007-REPLY TO EXAMINATION REPORT.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="250104-method-and-system-for-providing-code-signing-services.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="250106-method-for-manufacturing-an-austenitic-product-and-its-use-thereof.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>250105</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>465/KOLNP/2007</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>49/2011</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>09-Dec-2011</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>07-Dec-2011</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>08-Feb-2007</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>CEPHALON, INC</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>41, MOORES ROAD, P.O.BOX 4011, FRAZER, PA 19355</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>WILHELM HAUCK</td>
											<td>21 GREEN VALLEY ROAD, WALLINGFORD, PENNSYLVANIA 19086</td>
										</tr>
										<tr>
											<td>2</td>
											<td>YVAN RULAND</td>
											<td>NOVASEP ASIA/APPLEXION-ORELIS-NOVASEP, HUI YIN PLAZA, SOUTH TOWER, #1401, 2088 HUASHAN ROAD, 200030 SHANGHAI</td>
										</tr>
										<tr>
											<td>3</td>
											<td>NELSON LANDMESSER</td>
											<td>278 EDINBURGH ROAD, EXTON, PENNSYLVANIA 19341</td>
										</tr>
										<tr>
											<td>4</td>
											<td>JOHN MALLAMO</td>
											<td>98 MACLEOD POND ROAD, GLENMOORE, PENNSYLVANIA 19343</td>
										</tr>
										<tr>
											<td>5</td>
											<td>OLIVER LUDEMANN-HOMBOURGER</td>
											<td>62 RUE DU MARÉCHAL DE LATTRE DE TASSIGNY, F-54340 POMPEY.</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07B57/00,C07C317/24</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/IB2005/002706</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2005-09-13</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>04292199.9</td>
									<td>2004-09-13</td>
								    <td>EUROPEAN UNION</td>
								</tr>
								<tr>
									<td>2</td>
									<td>60/611,511</td>
									<td>2004-09-20</td>
								    <td>EUROPEAN UNION</td>
								</tr>
								<tr>
									<td>3</td>
									<td>11/224,250</td>
									<td>2005-09-12</td>
								    <td>EUROPEAN UNION</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/250105-an-industrial-scale-method-of-obtaining-an-enantiomer-of-modafinil by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 14:37:18 GMT -->
</html>
